RPFGX
Price
$72.75
Change
-$0.04 (-0.05%)
Updated
Aug 11 closing price
Net Assets
1.11B
SFPCX
Price
$9.93
Change
-$0.00 (-0.00%)
Updated
Aug 11 closing price
Net Assets
1.02M
Interact to see
Advertisement

RPFGX vs SFPCX

Header iconRPFGX vs SFPCX Comparison
Open Charts RPFGX vs SFPCXBanner chart's image
Davis Financial A
Price$72.75
Change-$0.04 (-0.05%)
VolumeN/A
Net Assets1.11B
Saratoga Financial Service C
Price$9.93
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.02M
RPFGX vs SFPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RPFGX vs. SFPCX commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPFGX is a Buy and SFPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPFGX has more cash in the bank: 1.11B vs. SFPCX (1.03M). RPFGX pays higher dividends than SFPCX: RPFGX (1.35) vs SFPCX (0.00). RPFGX was incepted earlier than SFPCX: RPFGX (34 years) vs SFPCX (25 years). SFPCX (4.88) is less costly to investors than RPFGX (0.94). SFPCX is a more actively managed with annual turnover of: 32.00 vs. RPFGX (2.00). SFPCX has a lower initial minimum investment than RPFGX: SFPCX (250) vs RPFGX (1000). RPFGX annual gain was more profitable for investors over the last year : 31.10 vs. SFPCX (18.64). RPFGX return over 5 years is better than : 106.05 vs. SFPCX (63.05).
RPFGXSFPCXRPFGX / SFPCX
Total Expense Ratio0.944.8819%
Annual Report Gross Expense Ratio0.944.8819%
Fund Existence34 years25 years-
Gain YTD16.0387.468215%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B1.03M108,488%
Annual Yield % from dividends1.350.00-
Returns for 1 year31.1018.64167%
Returns for 3 years55.8025.54219%
Returns for 5 years106.0563.05168%
Returns for 10 years93.9726.34357%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THRY13.431.02
+8.22%
Thryv Holdings
PHM123.333.13
+2.60%
Pultegroup
LPCN2.970.02
+0.68%
Lipocine
SBRA18.63-0.01
-0.05%
Sabra Health Care REIT
ELDN2.66-0.05
-1.85%
Eledon Pharmaceuticals